Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIA-AF: Rhythm-Guided Antithrombotic Strategy After AF Ablation in Patients With Prior DES
NCT07496281Phase 4Not yet recruiting
- Sponsor
- Ewha Womans University Mokdong Hospital
- Start
- Mar 2027
- Primary completion
- Feb 2032
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Atrial fibrillation (AFib) and coronary artery disease (CAD) (2 arms), sponsored by Ewha Womans University Mokdong Hospital. Primary endpoint: Composite net clinical outcome events at 24 months. Planned start Mar 2027; status: not yet recruiting.
02
Conditions
Atrial fibrillation (AFib)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT07496281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07496281.